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The spontaneous development of destructive
polyarthritis in mice transgenic for an autoreactive T-cell
receptor supports the notion that a failure of T-cell self-
tolerance can lead to similar diseases in humans, and
sheds new light on the role of peripheral tolerance in the
avoidance of such pathological immune responses.
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The etiology of chronic systemic inflammatory diseases
such as rheumatoid arthritis is unknown. Nevertheless,
the increased incidence and severity of such illnesses in
individuals carrying particular alleles of the major histo-
compatibility complex (MHC), the presence of CD4
(helper) T cells within chronically inflamed tissues and
the beneficial effects of depleting CD4 T cells have led to
the view that aberrant helper T-cell responses are
involved [1]. It has been suggested that an infectious
agent, and the consequent activation of pathogen-specific
helper T cells, cause rheumatoid arthritis. The similarities
between rheumatoid arthritis and better-defined chronic
infectious arthritic diseases, such as Lyme disease, and the
presence of T cells that can recognize components of
bacteria in the synovial tissues of rheumatoid arthritis
patients, both support such a position. 
As yet, however, no pathogenic agent has been identified
that might be responsible for initiating rheumatoid arthri-
tis. An alternative suggestion is that rheumatoid arthritis is
the result of pathological manifestations of T-cell auto-
reactivity caused by a failure of self-tolerance mecha-
nisms. Consistent with this, rheumatoid arthritis is
frequently associated with autoantibodies such as rheuma-
toid factors, and destructive arthritis can be induced in
rodents following immunization with constituents of the
normal articular cartilage. Perhaps the most attractive
hypothesis is that rheumatoid arthritis is caused by some
combination of genetic proclivity to autoimmunity and an
inciting infectious agent.
Despite the suggestive evidence, many rheumatologists
remain unconvinced that T cells are important to the
pathogenesis of rheumatoid arthritis. It has been argued
that synovial T cells are unlikely to play a causative role in
the development of the illness, as such T cells appear to
be functionally defective in their responses to mitogenic
stimulation in vitro. Indeed, the large quantities of pro-
inflammatory cytokines present in arthritic joints are most
indicative of a chronic activation of synoviocytes and other
phagocytes [2].
Mathis and colleagues [3] have recently reported remark-
able observations that directly address these issues. Using
transgenic mice specifically designed to express a single
type of T-cell receptor on each of their CD4 helper T
cells, they unexpectedly found that, by one month of age,
the mice developed a chronic deforming polyarthritis
involving the toes, feet, ankles and knees, as well as the
corresponding forelimb joints, a pathology reminiscent of
rheumatoid arthritis. Evidence of systemic inflammatory
disease was also present, with hypergammaglobulinemia
and antibody deposits within multiple tissues. This onset
of spontaneous destructive polyarthritis in a T-cell recep-
tor transgenic mouse line is unprecedented.
The T-cell receptor genes used for the production of the
transgenic mouse line (called KRN mice) came from a T
cell specific for a bovine RNAse peptide antigen presented
by an I-Ak class II MHC molecule. However, this T-cell
receptor was subsequently found to recognize spleen cells
from the NOD (non-obese diabetic) strain of mice — that
is, KRN T cells could be activated by NOD splenocytes in
the absence of RNAse peptide. This particular specificity
is of critical importance, as the mice developed arthritis
only when the T-cell receptor transgenes were co-
expressed with the NOD strain I-Ag7 class II MHC mole-
cule, as in the transgenic offspring of a cross between KRN
and NOD mice (KRN × NOD F1 mice). Thus, the sponta-
neous development of arthritis seems to depend on the
recognition of self I-Ag7 molecules (and some endogenous
self-peptide) by the KRN transgenic T-cell receptor. Final
proof will depend on the demonstration that arthritis also
develops in mice that express the KRN transgenic T-cell
receptor in the absence of other endogenous T-cell recep-
tors, for example mice containing targeted mutations in the
endogenous T-cell receptor a locus.
T cells capable of responding against self MHC molecules
are usually killed before their maturation in the thymus,
in order to maintain immune self-tolerance [4]. Consistent
with this, most of the immature T cells were found to be
killed in the KRN × NOD F1 mice early in life. However,
with increasing age and before the development of arthri-
tis, CD4 helper T cells accumulated in the thymus,
spleen and synovial fluid. A higher proportion of these
cells seemed to express endogenously rearranged T-cell
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receptor genes — encoding a and/or b-chains — and
made reduced levels of the transgenic ab heterodimer,
perhaps suggesting that the cells with the highest level of
autoreactive T-cell receptor expression were preferen-
tially eliminated during their development. Additionally,
the peripheral T cells were more likely to express activa-
tion markers — CD44high, CD62Llow and CD45RBlow —
indicating a recent recognition of antigen in the periphery.
This age-associated failure of intrathymic clonal deletion
of the T-cell receptor transgenic T cells could reflect a
progressive reduction in the thymic expression of I-Ag7 or
the relevant self-peptide presented by this MHC mole-
cule. Alternatively, clonal deletion may simply be over-
whelmed by the large number of maturing autoreactive
CD4 helper-type T cells that can be generated in the
thymus in these mice. The solution to this problem awaits
the isolation and identification of the self-peptide respon-
sible for the apparent autoreactivity in this model. Regard-
less of the mechanism, the spontaneous development of
polyarthritis in the KRN × NOD F1 mice appears to begin
with a breakdown in thymic self-tolerance to a widely-dis-
tributed self-peptide–MHC class II molecule complex.
This discovery provides strong evidence that autoreactive
T cells can initiate a disease like rheumatoid arthritis.
A paradoxical feature of this study is that, at a time when
the mice were affected by arthritis, peripheral T-cell
receptor transgenic T cells were found to be almost com-
pletely unresponsive to stimulation in vitro with the
RNAse peptide. This functional impairment suggests that
a peripheral tolerance mechanism has attempted to inhibit
their autoaggressive behavior. Other recent studies on the
fate of T-cell receptor transgenic T cells following in vivo
exposure to antigen have indicated that antigen stimula-
tion in the presence of inflammation caused by adjuvants
or microbial products induces proliferation and the main-
tenance of antigen responsiveness, but that antigen recog-
nition in the absence of inflammation induces only
transient proliferation in the spleen and lymph nodes fol-
lowed by a partial peripheral deletion, with the surviving
T cells left in an ‘anergic’ or functionally impaired state
Figure 1
A model of self-antigen-specific T cells in
health and in autoimmune disease. T cells with
antigen receptors specific for a self-peptide
are shown in red. (a) In normal individuals,
self-antigen-specific T cells only occasionally
enter the peripheral immune system. Contact
with the self-antigen in the periphery fails to
induce their proliferation and instead results in
a persistent impairment in lymphokine
secretion (light grey ring). In contrast, contact
with a microbial antigen induces other T cells
to expand in number and maintains their
capacity to secrete lymphokines at high levels
(dark grey rings). (b) In older KRN × NOD F1
mice, self-antigen-specific T cells leave the
thymus at relatively high frequency and
accumulate in the periphery. Contact with
self-antigen fails to induce further expansion
and down-regulates the functional
responsiveness of the cells; however, this
large population still mediates an effector
response that leads to polyarthritis. (c) In
individuals with rheumatoid arthritis, self-
antigen-specific T cells may be recruited and
clonally expanded during a T-cell response
directed against a microbial antigen.
Peripheral tolerance mechanisms act to
reduce the functional capacity of these
autoreactive T cells; nevertheless, their high
numbers result in pathological effector
responses that lead to chronic joint
destruction.
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[5]. In the absence of a pathogen or injury, such a toler-
ance-inducing environment would be expected when the
KRN T cells encounter self-antigen in the periphery.
Peripheral deletion of T-cell receptor transgenic T cells
may or may not occur in the older KRN × NOD F1 mice;
regardless, the accumulation of anergic T cells with a
recently activated phenotype is consistent with peripheral
tolerance induction upon recognition of self-antigen.
Despite the in vitro functional impairment exhibited by
the T-cell receptor transgenic T cells from older
KRN × NOD F1 mice, these animals still developed
destructive polyarthritis, presumably as a consequence of
the accumulation of autoreactive CD4 helper T cells in
the joints. This implies a failure of peripheral tolerance
mechanisms to block the development of pathological
self-reactivity. This failure is perhaps not unexpected, as
peripheral tolerance mechanisms may not be capable of
globally suppressing all the potential effector responses of
such helper T cells [6]. Although T-cell clonal anergy in
vitro is manifested by a profound block in interleukin-2
(IL-2) production and clonal expansion, the production of
interferon-g and IL-4 is relatively unaffected, as is expres-
sion of cytotoxic activity [7]. Likewise, experiments
designed to induce peripheral T-cell tolerance in vivo
have failed to demonstrate a significant effect on the
helper activity of the T cells if they are first primed (and
presumably expanded) in response to immunization with
antigen and adjuvant [8].
Anergic T cells in vivo may therefore be impaired in their
ability to undergo clonal expansion, but may still be
capable of influencing the development of B-cell antibody
responses or killing antigen-bearing target cells. Under
normal circumstances, this type of functional unrespon-
siveness would be effective at preventing autoimmunity
by limiting the capacity of self-antigen-specific T cells to
expand to large numbers in the periphery (Fig. 1a). This
effectiveness may be lost in the setting of the older
KRN × NOD F1 mice, because self-antigen-specific T
cells escape the thymus in large numbers every day. Thus,
even though these T cells acquire a proliferative defect
because of peripheral tolerance induction, they would be
numerous enough to facilitate the effector responses that
cause autoimmune pathology (Fig. 1b). The earlier
finding by Forster et al. [9] that peripheral tolerance was
maintained in self-antigen-specific T cells when they
were present at low frequency, whereas at a higher fre-
quency these same cells caused autoimmune pathology,
supports this idea.
This situation may also describe the dynamics of T-cell
participation in the initiation of clinically important
autoimmunity in people who eventually develop a sys-
temic inflammatory polyarthritis. Perhaps such individuals
accumulate self-antigen-specific T cells to relatively high
numbers as a consequence of infection — given its poten-
tial for simultaneous expansion of bystander or cross-reac-
tive self-antigen-specific T-cell clones — in the setting of
a genetically pre-determined weakness in peripheral toler-
ance (Fig. 1c). Then, despite the best efforts of the
immune system to inactivate these T cells, they retain the
capacity to initiate and perpetuate an inflammatory
response directed against that self-antigen. The observa-
tion that CD4 helper T cells within the synovial tissues of
rheumatoid arthritis patients show little capacity for IL-2
secretion or proliferation, and yet retain a remarkable
capacity to provide help to B cells for the production of
antibodies [10], is consistent with such a scenario.
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